Kwong, US
Ambrose Kwong, Westford, MA US
Patent application number | Description | Published |
---|---|---|
20130003728 | PROVIDING EXTENDED ADMINISTRATIVE GROUPS IN COMPUTER NETWORKS - In general, techniques are described for providing extended administrative groups in networks. A network device comprising an interface and a control unit may implement the techniques. The interface receives a routing protocol message that advertises a link. This message includes a field for storing first data associated with the link in accordance with the routing protocol. The field is defined by the routing protocol as a field having a different function from an administrative group field defined by the same routing protocol. The control unit determines that this field has been repurposed to store second data, wherein this second data specifies an extended administrative group for the link different from those that may be specified by the administrative group field. The control unit then updates routing information to associate the advertised link with the extended administrative group and performs path selection to select paths based on the updated routing information. | 01-03-2013 |
Andrew Kwong, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20080244148 | VoIP Enabled Femtocell with a USB Transceiver Station - Telephone calls between a mobile station (MS) and the mobile network or PSTN are routed through the Internet via VoIP using a femtocell, as opposed to the traditional macrocellular network. The femtocell can comprise a USB Transceiver Station that is connected to a personal computer through a universal serial bus port, which provides both power and a multi-megabit per second connection between the personal computer and the USB transceiver station. The USB transceiver station can comprise a microcontroller to manage signaling between the RF front end/baseband processor and the personal computer, as well as a precise timing mechanism to assist the synchronization of femtocell timing with the surrounding macrocellular network, if it is present. The USB transceiver station can have a compact form factor that that facilitates a high degree of portability by the subscriber, such as being readily attachable to their keychain. | 10-02-2008 |
20120020293 | VOIP ENABLED FEMTOCELL WITH A USB TRANSCEIVER STATION - Telephone calls between a mobile station (MS) and the mobile network or PSTN are routed through the Internet via VoIP using a femtocell, as opposed to the traditional macrocellular network. The femtocell can comprise a USB Transceiver Station that is connected to a personal computer through a universal serial bus port, which provides both power and a multi-megabit per second connection between the personal computer and the USB transceiver station. The USB transceiver station can comprise a microcontroller to manage signaling between the RF front end/baseband processor and the personal computer, as well as a precise timing mechanism to assist the synchronization of femtocell timing with the surrounding macrocellular network, if it is present. The USB transceiver station can have a compact form factor that that facilitates a high degree of portability by the subscriber, such as being readily attachable to their keychain. | 01-26-2012 |
Andrew W. Kwong, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20100290365 | MULTI-LEVEL HOSTED INBOUND ADMINISTRATION FOR A TELEPHONY SYSTEM - A multi-level hosted inbound administration platform for a packet-switched telephony system is provided. The platform provides services for managing the distribution and features of direct inward dialing numbers (DIDs). The platform allows a client to import or purchase DIDs, make DIDs available to sub-distributors, and provision them to end-users. The platform allows sub-distributors to reserve and activate DIDs, make DIDs available to downstream sub-distributors, and provision them to end-users. The platform provides a billing structure for DID usage, with charges being applied on a one-time, monthly, or variable basis. The platform also allows clients and sub-distributors to charge for inbound services based on per-minute or per-usage charges. | 11-18-2010 |
Ann Kwong, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100172866 | Combination Therapy for the Treatment of HCV Infection - The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention. | 07-08-2010 |
20110229874 | COMPOSITIONS AND METHODS USEFUL FOR HCV INFECTION - The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV. | 09-22-2011 |
20110244549 | HEPATITIS C VIRUS VARIANTS - The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient. | 10-06-2011 |
20120295843 | COMBINATION THERAPY FOR THE TREATMENT OF HCV INFECTION - The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention. | 11-22-2012 |
20130071834 | COMPOSITIONS AND METHODS USEFUL FOR HCV INFECTION - The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV. | 03-21-2013 |
Ann D. Kwong, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100189688 | Dose forms comprising VX-950 and their dosage regimen - The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs. | 07-29-2010 |
20130344476 | HEPATITIS C VIRUS VARIANTS - The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient. | 12-26-2013 |
Ann Dak-Yee Kwong, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20120088904 | ANALYSIS OF HCV GENOTYPES - A method for predicting response of a patient infected with HCV-1a to interferon treatment | 04-12-2012 |
20120129155 | METHODS FOR AMPLIFYING HEPATITIS C VIRUS NUCLEIC ACIDS - A method of amplifying an HCV nucleic acid in an HCV infected sample comprises amplifying a segment of a DNA template that is complementary to a genome of HCV RNA from the sample by a two-stage PCR, wherein a first stage PCR employs a first outer primer and a second outer primer, and a second stage PCR employs a first inner primer and a second inner primer. The nucleotide sequence of the first outer primer comprises a nucleotide sequence as set forth in SEQ ID NO: 2; or SEQ ID NO:9, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 9. The nucleotide sequence of the second outer primer comprises a nucleotide sequence set forth in SEQ ID NO: 3 or 4; or a nucleotide sequence as set forth in SEQ ID NO: 10 or 11, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 10 and 11. The nucleotide sequence of the first inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 5; or SEQ ID NO:12, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 12. The nucleotide sequence of the second inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 6 or 7; or a nucleotide sequence as set forth in SEQ ID NO: 13 or 14, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 13 and 14. | 05-24-2012 |
20140050697 | ANALYSIS OF HCV GENOTYPES - A method for predicting response of a patient infected with HCV-1a to interferon treatment. | 02-20-2014 |
20140199684 | METHODS FOR AMPLIFYING HEPATITIS C VIRUS NUCLEIC ACIDS - A method of amplifying an HCV nucleic acid in an HCV infected sample comprises amplifying a segment of a DNA template that is complementary to a genome of HCV RNA from the sample by a two-stage PCR, wherein a first stage PCR employs a first outer primer and a second outer primer, and a second stage PCR employs a first inner primer and a second inner primer. The nucleotide sequence of the first outer primer comprises a nucleotide sequence as set forth in SEQ ID NO: 2; or SEQ ID NO:9, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 9. The nucleotide sequence of the second outer primer comprises a nucleotide sequence set forth in SEQ ID NO: 3 or 4; or a nucleotide sequence as set forth in SEQ ID NO: 10 or 11, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 10 and 11. The nucleotide sequence of the first inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 5; or SEQ ID NO:12, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 12. The nucleotide sequence of the second inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 6 or 7; or a nucleotide sequence as set forth in SEQ ID NO: 13 or 14, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 13 and 14. | 07-17-2014 |
20140296201 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 10-02-2014 |
Arnie W. Kwong, Saint Paul, MN US
Patent application number | Description | Published |
---|---|---|
20140176940 | HAND HELD TOXICITY TESTER - A system and method for reliably testing for toxic substances is described. Based on spectrographic means, the system embodies one or more types of spectrometers, designed for the detection of toxic elements such as lead, and alternatively designed for the detection of toxic compounds such as asbestos. By restricting the broad functionality common to a typical spectrometer, dramatic cost reductions can be made permitting the device to be cost-effectively manufactured and made available to the typical consumer. The device is can be portable and incorporates safety systems to inhibit improper use. | 06-26-2014 |
Arnold W. Kwong, Saint Paul, MN US
Patent application number | Description | Published |
---|---|---|
20080219866 | Generation and Management of Mass Air Flow - Systems and methods for generating high velocity mass air flows are disclosed. High velocity mass air flow (air charging) devices are needed in a variety of research, industrial, commercial, and consumer applications. The exemplary systems and apparatus described incorporate an electric motor subassembly, an air effector subassembly, a highly intelligent apparatus controller subassembly (and interfaces), and linked sensors, connectors, and wiring. The exemplary method described includes the operational apparatus controller subassembly (e.g., elements, logic, and behavior) that controls the entire apparatus' functions and interactions. | 09-11-2008 |
Benedict Kwong, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20100201633 | TOUCH SCREEN WITH IMPROVED OPTICAL PERFORMACE - An improved touch screen has enhanced optical performance and aesthetic quality. The sense electrodes and other traces on the touch screen are made less invisible to the user by substantially filling the space between the conductive traces or electrodes with isolated regions that match the light transmission characteristics of the electrodes. In capacitive and resistive touch screens, the space between ITO electrodes and other traces on the substrate is substantially filled with ITO to match the electrodes. The space between electrodes is preferably filled with isolated regions of ITO formed in a pattern. The isolated regions in the pattern may be shaped and the electrodes notched to create non-linear spaces to further reduce the visibility of the pattern. Further, the space between ITO traces can be filled with irregular-shaped ITO regions to further reduce the visibility of the space. | 08-12-2010 |
Cecil D. Kwong, Homewood, AL US
Patent application number | Description | Published |
---|---|---|
20140242027 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 08-28-2014 |
Cecil D. Kwong, Birmingham, AL US
Patent application number | Description | Published |
---|---|---|
20110286964 | AZO-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 11-24-2011 |
20110286965 | ETHENYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (A): (Chemical formula should be inserted here as it appears on abstract in paper form) (A) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein wherein each of R, R | 11-24-2011 |
20110318305 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 12-29-2011 |
20120107271 | ETHYNYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R | 05-03-2012 |
Charlotte C. Kwong, Beaverton, OR US
Patent application number | Description | Published |
---|---|---|
20140239995 | TEST PROBES - The formation of test probe structures is described. One test probe structure includes a tip portion and a handle portion spaced a distance away from the tip portion. The test probe structure also includes a body bend portion positioned between the tip portion and the handle portion, and an intermediate portion positioned between the body bend portion and the handle portion. The body bend portion may include a curved shape extending from the intermediate portion to the tip portion. The tip portion may be formed to be offset from a longitudinal axis defined by the intermediate portion. The test probe structure defines a length and includes a cross-sectional area that is different at a plurality of positions along the length. Other embodiments are described and claimed. | 08-28-2014 |
Charlotte C. Kwong, Aloha, OR US
Patent application number | Description | Published |
---|---|---|
20150008950 | MANUFACTURING ADVANCED TEST PROBES - Embodiments relate to the formation of test probes. One method includes providing a bulk sheet of an electrically conductive material. A laser is used to cut through the bulk sheet in a predetermined pattern to form a test probe. Other embodiments are described and claimed. | 01-08-2015 |
Chun K. Kwong, Pontiac, MI US
Patent application number | Description | Published |
---|---|---|
20150056041 | DUAL-LAYER DRY BOLT COATING - A bolt includes a body and a threaded portion formed on the body. The bolt further includes a phosphate base coat, which covers at least the body and is in direct contact with the body. The bolt also includes a PTFE overcoat, which substantially covers the phosphate base coat and is separated from the body of the bolt by the phosphate base coat. | 02-26-2015 |
Dim-Lee Kwong, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20080224236 | METAL GATE ELECTRODE FOR SEMICONDUCTOR DEVICES - A gate electrode for semiconductor devices, the gate electrode comprising a mixture of a metal having a work function of about 4 eV or less and a metal nitride. | 09-18-2008 |
20090163005 | Schottky barrier source/drain N-MOSFET using ytterbium silicide - A method of fabricating an N-type Schottky barrier Source/Drain Transistor (N-SSDT) with ytterbium silicide (YbSi | 06-25-2009 |
20090179281 | Schottky barrier source/drain N-MOSFET using ytterbium silicide - An N-type Schottky barrier Source/Drain Transistor (N-SSDT) that uses ytterbium silicide (YbSi | 07-16-2009 |
Elizabeth Kwong, Cranford, NJ US
Patent application number | Description | Published |
---|---|---|
20110237541 | TRANSDERMALLY ADMINISTERED ALISKIREN - Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a desired therapeutic effect. Use of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving a desired therapeutic effect. Method for achieving a desired therapeutic effect by transdermal administration of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s). | 09-29-2011 |
Gabriel Kwong, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20100240050 | Methods and Products For In Vivo Enzyme Profiling - The present invention relates to methods and products associated with in vivo enzyme profiling. In particular, the invention relates to methods of in vivo processing of exogenous molecules followed by detection of signature molecules as representative of the presence of active enzymes associated with diseases or conditions. The invention also relates to products, kits, and databases for use in the methods of the invention. | 09-23-2010 |
Gabriel A. Kwong, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140234431 | METHODS AND PRODUCTS FOR IN VIVO ENZYME PROFILING - The present invention relates to methods and products associated with in vivo enzyme profiling. In particular, the invention relates to methods of in vivo processing of exogenous molecules followed by detection of signature molecules as representative of the presence of active enzymes associated with diseases or conditions. The invention also relates to products, kits, and databases for use in the methods of the invention. | 08-21-2014 |
20140303014 | MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS - Some aspects of this invention provide reagents and methods for the sensitive, quantitative and simultaneous detection of target analytes in complex biological samples by liquid chromatography tandem mass spectrometry (LC MS/MS). Some aspects of this invention provide affinity reagents encoded with mass reporters for the sensitive and quantitative translation of an analyte of interest into a mass tag. The reagents and methods provided herein have general utility in analyte detection and encoding, for example, in biomolecular profiling, molecular diagnostics, and biochemical encoding. | 10-09-2014 |
20140363833 | AFFINITY-BASED DETECTION OF LIGAND-ENCODED SYNTHETIC BIOMARKERS - The invention relates to methods and products associated with in vivo enzyme profiling. In particular, biomarker nanoparticles capable of quantitatively detecting enzymatic activity in vivo are described. These nanoparticles can be used to detect in vivo enzyme activity. The invention also relates to products, kits, and databases for use in the methods of the invention. | 12-11-2014 |
Gabriel Abner Kwong, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140364368 | STIMULUS RESPONSIVE NANOCOMPLEXES AND METHODS OF USE THEREOF - The present invention provides stimulus responsive nanocomplexes comprising a masking moiety, e.g., a peptide, and a therapeutic moiety, e.g., an anti-coagulant. The invention also provides methods for treating or preventing a condition, such as a hypercoagulable state, e.g., blood clotting disorders or a cardiovascular disease, in a subject. | 12-11-2014 |
Hank Kwong, Farmington Hills, MI US
Patent application number | Description | Published |
---|---|---|
20090275440 | VEHICLE RESPONSE DURING VEHICLE ACCELERATION CONDITIONS - A vehicle control method for transitioning through transmission lash regions is described using a variety of information, such as, for example, gear ratio, clutch slippage, etc. Further, different adjustment of spark and throttle angle is used to provide a rapid torque response while still reducing effects of the lash. Finally, transitions taking into account both slipping and non-slipping transmissions are described. | 11-05-2009 |
20110034298 | SYSTEM AND METHOD FOR IMPROVED VEHICLE RESPONSE DURING VEHICLE ACCELERATION CONDITIONS - A vehicle control method for a vehicle having an internal combustion engine coupled to a torque converter is described. In one embodiment, the engine air flow and spark are adjusted to control torque converter operation. The method can improve vehicle response to driver accelerator commands | 02-10-2011 |
20140106934 | SYSTEM AND METHOD FOR IMPROVED VEHICLE RESPONSE DURING VEHICLE ACCELERATION CONDITIONS - A vehicle control method for a vehicle having an internal combustion engine coupled to a torque converter is described. In one embodiment, the engine air flow and spark are adjusted to control torque converter operation. The method can improve vehicle response to driver accelerator commands. | 04-17-2014 |
Hank L. Kwong, Farmington Hills, MI US
Patent application number | Description | Published |
---|---|---|
20140081561 | User Interface For Automatic Start-Stop System and Method of Controlling The Same - Vehicles equipped with an automatic start-stop system may include an interface for conveying inhibitors preventing an engine from auto-stopping in addition to the status of the automatic start-stop system. The system may identify one or more inhibitors actively preventing an auto-stop event from occurring and select at least one of the active inhibitors based on a priority scheme. The interface may communicate the at least one selected inhibitor to a driver using a display or a speaker, or both. | 03-20-2014 |
20140278019 | SYSTEM AND METHOD FOR OPTIMIZING AVAILABILITY OF VEHICLE ENERGY CONSERVING MODES - Vehicles capable of operating in an energy conserving mode may include an interface for conveying inhibitors preventing activation of the energy conserving mode. The system may identify the inhibiting features and prompt an operator of the vehicle for authorization to disable the inhibiting features or adjust the feature states to enable the energy conserving mode. In response to receiving authorization, the system may automatically control feature interfaces to remove inhibits to the energy conserving mode. The interface may communicate active inhibitors to an operator using a display or a speaker, or both. Additionally, the interface may query the operator to approve automatic deactivation of the inhibiting features and facilitate the receipt of operator input to the query. | 09-18-2014 |
Hung Kwong, San Antonio, TX US
Patent application number | Description | Published |
---|---|---|
20110124061 | METHOD FOR PREPARATION OF POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHATIDYLSERINE - A method for the preparation of the polyunsaturated fatty acids-containing phosphatidylserine, the method comprising: combining L-serine with a fish liver phosphatidylcholine having a polyunsaturated fatty acid to form a mixture; reacting the mixture with phospholipase D to effect transphosphatidylation of L-serine and the phosphatidylcholine having polyunsaturated fatty acids to produce the polyunsaturated fatty acids-containing phosphatidylserine. | 05-26-2011 |
Hung Kwong, Malta, NY US
Patent application number | Description | Published |
---|---|---|
20090131368 | MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES - A chemical composition of a molecular species mixture of phospholipids, purified to at least 85% purity through chromatography purification, the chemical composition contains enriched both sn-1-acyl fatty chains/sn-2-docosahexaenoic acid molecular species and sn-1-ether fatty chains/sn-2-docosahexaenoic acid molecular species, the phospholipids are selected from the group consisting of: phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine. Methods using the above disclosed composition in mammals to treat various conditions. | 05-21-2009 |
20120116104 | MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES - A chemical composition of a molecular species mixture of phospholipids, purified to at least 85% purity through chromatography purification, the chemical composition contains enriched both sn-1-acyl fatty chains/sn-2-docosahexaenoic acid molecular species and sn-1-ether fatty chains/sn-2-docosahexaenoic acid molecular species, the phospholipids are selected from the group consisting of: phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine. Methods using the above disclosed composition in mammals to treat various conditions. | 05-10-2012 |
Joyce Y. Kwong, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20130066932 | CONSTANT GEOMETRY SPLIT RADIX FFT - An apparatus for performing a Fast Fourier Transform (FFT) is provided. The apparatus comprises a reorder matrix, symmetrical butterflies, and a memory. The reorder matrix is configured to have a constant geometry, and the butterflies are coupled in parallel to the reorder matrix. The memory is also coupled to the reorder matrix and each butterfly. The reorder matrix, the butterflies, and the memory can then execute a split radix algorithm. | 03-14-2013 |
Karric Kwong US
Patent application number | Description | Published |
---|---|---|
20080243366 | METHOD AND APPARATUS FOR DETECTING PRESENCE OF VEHICLE USING A MAGNETIC SENSOR EMPLOYING A MAGNETO-RESISTIVE EFFECT - Method using raw signal from magneto-resistive sensor through the use of recent variance (RV) of raw signal (RS) for first-capture of first time RV crosses variance detect, second-capture start enable for first time when RS crosses above raw detect and RV above variance detect, third-capture ending time when RS crosses below raw undetect and RV below variance undetect. Starting and ending times are products of the process, often used for traffic flow counts. Apparatus supporting this method as a processor and/or a vehicular sensor node. | 10-02-2008 |
Ka Yin Kwong, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20110150870 | FULLY HUMAN ANTI-HUMAN NKG2D MONOCLONAL ANTIBODIES - The invention relates to isolated fully human monoclonal antibodies having specificity for human NKG2D and compositions thereof. The invention further relates to methods for using such antibodies in treating diseases or conditions such as cancer, autoimmune disease, or infectious disease. | 06-23-2011 |
Kelvin Kwong, Tualatin, OR US
Patent application number | Description | Published |
---|---|---|
20110221841 | STRIPPING BLADE FOR STRIPPING MEDIA FROM A DRUM IN AN INKJET PRINTER - A stripper blade has been developed for high throughput inkjet printers. The stripper blade includes a metallic blade body having a first thickness that extends to a leading edge having a second thickness that is less than about 25% of the first thickness, and at least one beveled surface leading from the metallic blade body to the leading edge to form a stripping edge that facilitates separation of media from a drum. | 09-15-2011 |
Kenneth Kwong, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20150115956 | SYSTEM AND METHOD FOR QUIET MAGNETIC RESONANCE IMAGING - A system and method for performing quiet magnetic resonance imaging (“MRI”) are provided. An MRI system is directed to perform a pulse sequence that includes a magnetic field gradient s tapped through a plurality of different gradient component amplitude values in a manner that controls the difference between successive gradient amplitudes. In this way, force changes generated during the transition from one gradient component amplitude to the next are controlled, thereby resulting in a significant noise reduction. Additionally, the gradient amplitude values are ordered such that the transition of the gradient component amplitude in successive repetitions of the pulse sequence is controlled, thereby mitigating the generation of forces between pulse sequence repetitions. | 04-30-2015 |
Kennie Y. Kwong, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20110176491 | OPTIMIZING STATIC DICTIONARY USAGE FOR SIGNAL COMPRESSION AND FOR HYPERTEXT TRANSFER PROTOCOL COMPRESSION IN A WIRELESS NETWORK - A method includes receiving a registration request including a first dictionary definition. The registration request is associated with user equipment. The method includes transmitting to the user equipment a response including a second dictionary definition. The method includes transmitting subsequent messages to the user equipment if the first and second dictionary definitions agree, the subsequent messages being compressed using the first static dictionary. | 07-21-2011 |
Kwokshan Kwong, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20130313420 | COMBINED SONIC/PULSED NEUTRON CASED HOLE LOGGING TOOL - A through casing formation evaluation tool string | 11-28-2013 |
20140103202 | Combined Sonic/Pulsed Neutron Cased Hole Logging Tool - A through casing formation evaluation tool string | 04-17-2014 |
20140330520 | METHOD AND SYSTEM OF RESIN EVALUATION USING PULSED NEUTRON TOOLS - Resin evaluation using pulsed neutron tool. At least some of the example embodiments are methods including: interrogating an area behind a casing material within a borehole with a plurality of neutrons; obtaining a count rate of inelastic gammas of a first gamma detector for a particular borehole depth, wherein the inelastic gammas comprise gammas emitted in inelastic collisions of the plurality of neutrons with matter behind the casing material; determining an inelastic carbon-oxygen ratio from the inelastic count rate of the first gamma detector; and determining an indication of the composition of the matter behind the casing material from the inelastic carbon-oxygen ratio from the inelastic count rate of the first gamma detector. | 11-06-2014 |
20150185362 | Combined Sonic/Pulsed Neutron Cased Hole Logging Tool - A through casing formation evaluation tool string | 07-02-2015 |
20150241595 | TRIPLE PHASE EVALUATION OF FORMATION FLUIDS - Various embodiments include apparatus and methods to conduct a triple phase evaluation of a formation. The evaluation can be performed using a pulsed-neutron tool including a long detector and a detector to make sigma measurements. Additional apparatus, systems, and methods are disclosed. | 08-27-2015 |
Kwok-Shan Kwong, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20150108339 | PULSED-NEUTRON TOOL METHODS AND SYSTEMS FOR MONITORING CASING CORROSION - Casing condition is an important concern to oilfield operators. Systems and methods are disclosed herein for using neutron logging tools to measure casing condition, using windows in the gamma energy spectrum that are sensitive and insensitive to casing condition to obtain a ratio having a value that ranges between one extreme representative of completely absent casing and an opposite extreme representative of casing in good condition. The sensitive (“divergence”) window may be positioned at or near 7.65 MeV, the characteristic energy of gamma rays from a neutron capture event by an iron nucleus. The insensitive (“consistency”) window is preferably adjacent to the divergence window with a comparable size to the divergence window. A suitable division point between the windows may be about 6.25 MeV. | 04-23-2015 |
Louis Kwong, Warsaw, IN US
Patent application number | Description | Published |
---|---|---|
20140052192 | TROCHANTER ATTACHMENT DEVICE - A trochanter attachment device can include a plate for attachment to an inner portion of a greater trochanter of a femur, a collar for attaching the plate to a hip implant, and a fastener for securing the collar to a hip implant. The trochanter attachment device can include a groove or other feature for receiving a reinforcing material, such as a wire or a cable, such as to reinforce an attachment of the device to the greater trochanter and/or the hip implant. The trochanter attachment device can include an insert attachable to the plate and configured to attach the plate to the greater trochanter. All or a portion of the plate and/or the insert can include a porous material, such as to promote bone ingrowth of the greater trochanter. | 02-20-2014 |
Manlik Kwong, Corvallis, OR US
Patent application number | Description | Published |
---|---|---|
20110184759 | QUALITY IMPROVEMENT (QI) REVIEW SYSTEM AND METHOD - A computer-implemented clinical quality review method involving: for each of a plurality of medical problem types, storing a corresponding set of review criteria; receiving a plurality of electronic patient care records (ePCRs) from a medical service provider (MSP), each ePCR identifying a patient treated by the MSP and information about the medical care provided to that patient by the MSP, including: clinical problem type, clinical impressions, symptoms, and details about the evaluation of and treatment provided to that patient by the MSP; and for each ePCR: (i) determining whether the medical care meets the set of review criteria associated with the medical problem type identified in that ePCR; (ii) if the medical care passes the set of review criteria, approving the medical care provided to that patient and forwarding information about the medical care provided to that patient to a reporting system; and (iii) if the medical care does not pass the set of review criteria, generating a notification indicating that a manual review of the medical care provided to that patient is required. | 07-28-2011 |
Peter Kwong, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20150366961 | ANTIBODY EVOLUTION IMMUNOGENS - The present invention relates, in general, to HIV-1 and, in particular, to broadly neutralizing HIV-1 antibodies, and to HIV-1 immunogens and to methods of using such immunogens to induce the production of broadly neutralizing HIV-1 antibodies in a subject (e.g., a human). | 12-24-2015 |
Peter Kwong, Wheeling, IL US
Patent application number | Description | Published |
---|---|---|
20090104442 | Antimicrobial Gas Generating System - Gas generating and releasing articles consisting essentially of a polymer and a gas generating solid dispersed therein are described. The article generates a controlled fast and followed by a slow release gas in response to moisture. | 04-23-2009 |
Peter Kwong, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20090191235 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS AND TRIGGERING HIV-1 ENVELOPE TO REVEAL CRYPTIC V3-LOOP EPITOPES - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 07-30-2009 |
20120034255 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 02-09-2012 |
20120282264 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes. | 11-08-2012 |
20120328641 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 12-27-2012 |
20130251726 | NOVEL HIV -1 BROADLY NEUTRALIZING ANTIBODIES - The present application relates novel HIV-1 broadly neutralizing antibodies. The antibodies of the present invention are further characterized by their ability to bind epitopes from the Env proteins. The invention also provides light and heavy chain variable region sequences. Compositions for prophylaxis, diagnosis and treatment of HIV infection are provided. | 09-26-2013 |
20140271699 | PREFUSION RSV F PROTEINS AND THEIR USE - Disclosed are immunogens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the immunogens and methods of producing the immunogens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the immunogen to the subject. | 09-18-2014 |
20140348785 | NEUTRALIZING GP41 ANTIBODIES AND THEIR USE - Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are compositions including the disclosed antibodies that specifically bind gp41, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of HIV-1 in a biological sample, or detecting an HIV-1 infection or diagnosing AIDS in a subject. In additional, the broad neutralization breadth of the disclosed antibodies makes them ideal for treating a subject with an HIV infection. Thus, disclosed are methods of treating and/or preventing HIV infection. | 11-27-2014 |
20140348865 | IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY - Disclosed are HIV immunogens. Also disclosed are nucleic acids encoding these immunogens and methods of producing these antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject. | 11-27-2014 |
Peter Kwong, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20140205607 | FOCUSED EVOLUTION OF HIV-1 NEUTRALIZING ANTIBODIES REVEALED BY CRYSTAL STRUCTURES AND DEEP SEQUENCING - Antibody VRC01 represents a human immunoglobulin that neutralizes—˜90% of diverse HIV-1 isolates. To understand how such broadly neutralizing HIV-1 antibodies develop and recognize the viral envelope, we used X-ray crystallography and 454 pyrosequencing to characterize additional antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding of different antibodies to the same CD4-binding-site epitope. Antibody recognition was achieved through the evolution of complementary contact domains that were generated in diverse ways. Phylogenetic analysis of expressed heavy and light chains determined by deep sequencing revealed a common pathway of antibody heavy chain maturation confined to IGHV1-2*02 lineage that could pair with different light chains. The maturation pathway inferred by antibodyomics reveals that diverse antibodies evolve to a highly affinity-matured state to recognize an invariant viral structure, providing insight into the development and evolution of broadly neutralizing HIV-1 immunity. | 07-24-2014 |
Peter D. Kwong, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20140377219 | HIV INHIBITORS - Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection with, or treat infection caused by, human immunodeficiency viruses. | 12-25-2014 |
Peter D. Kwong, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20090110690 | Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens - The present disclosure relates to stabilized forms of the HIV gp120 envelope protein in complex with the broadly neutralizing CD4-binding site antibody b12, to crystalline forms of the stabilized forms of the HIV gp120 envelope protein in complex with the broadly neutralizing CD4-binding site antibody b12, and to the high resolution structure obtained from these crystals by X-ray diffraction methods. Methods for identifying immunogenic polypeptides based on these structures are also disclosed. | 04-30-2009 |
20090162390 | Molecular Scaffolds for HIV-1 Immunogens - Methods and compositions are provided which employ chimeric polypeptides having at least one heterologous epitope for a human immunodeficiency virus type 1 (HIV-1) neutralizing antibody. These chimeric polypeptides behave as molecular scaffolds which are capable of presenting the various heterologous HIV-1 epitopes. The invention demonstrates that a heterologous epitope recognized by the HIV-1 neutralizing antibody can be more fully exposed to neutralizing antibodies when presented within the backbone of the chimeric polypeptide than when the epitope is presented within the context of an HIV-1 backbone. Polynucleotides encoding these chimeric polypeptides are also provided. Immunogenic compositions are provided which comprise a chimeric polypeptide having at least one heterologous epitope that interacts with an HIV-1 neutralizing antibody. Immuno genie compositions comprising chimeric polynucleotides encoding the chimeric polypeptides of the invention are also provided. Vaccines comprising such immunogenic compositions are also provided. Further provided are methods which employ the immunogenic compositions of the invention. Such methods include, for example, methods for eliciting an immune response in a subject, methods for generating antibodies specific for the chimeric polypeptide or the chimeric polypeptide, and methods for inhibiting or preventing infection by HIV-1 in a subject. | 06-25-2009 |
20090220536 | HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 - This invention relates to novel peptide immunogens that generate an immune response in mammals against HIV gp41, to pharmaceutical compositions that comprise such immunogens, and to methods of treating Immunodeficiency disease, especially HIV infection and AIDS, that employ such pharmaceutical compositions. | 09-03-2009 |
20100068217 | EPITOPE-TRANSPLANT SCAFFOLDS AND THEIR USE - Computational protocols for the design of epitope-protein scaffolds which elicit selected neutralizing antibodies are disclosed, and related compositions and uses. | 03-18-2010 |
20120034254 | ANTIGENIC CLOAKING AND ITS USE - Disclosed are antigens that include a target epitope that is defined by atomic coordinates of those amino acids of the antigen that contact an antibody of interest that specifically binds the antigen. The disclosed antigens have between about 10% and about 90% of surface exposed amino acid residues located exterior of the target epitope substituted as compared to a wild-type antigen and less than about 10% of the non-surface exposed amino acid residues substituted as compared to a wild-type antigen. Also disclosed are nucleic acids encoding these antigens and methods of producing these antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject. | 02-09-2012 |
20120237523 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes. | 09-20-2012 |
20120244166 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and uses of these antibodies, are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes. | 09-27-2012 |
20120315270 | RSV IMMUNOGENS, ANTIBODIES AND COMPOSITIONS THEREOF - The present invention provides immunogens that protect against RSV infection. The present invention also provides antibody proteins that protect against RSV infection. Such immunogens and antibody proteins are produced based on three-dimensional models also included in the invention. One model is of a complex between motavizumab and its antibody-binding domain on RSV fusion (F) protein. A second model is of a complex between 10 IF antibody and its antibody-binding domain on RSV F protein. The immunogens disclosed herein have been modified to elicit a humoral response against RSV F protein without eliciting a significant cell-mediated response against RSV. Such immunogens can comprise a scaffold into which RSV contact residues are embedded. The present invention also includes methods that utilize the disclosed three-dimensional models to produce immunogens and antibody proteins of the present invention. Also disclosed are methods of using the disclosed immunogens, for example to protect individuals from RSV infection. Also disclosed are methods of using the disclosed antibody proteins, for example to protect individuals from RSV infection. | 12-13-2012 |
20140322163 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Monoclonal neutralizing antibodies that specifically bind to HIV-1 gp120 and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV infection is disclosed. | 10-30-2014 |
20140350113 | CD4-MIMETIC INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF - Described herein are small-molecule mimics of CD4, which both enter the Phe43 cavity and target Asp368 of gp120, the HIV-1 envelope protein. Also described herein are methods of using these compounds to inhibit the transmission or progression of HIV infection. These compounds exhibit antiviral potency greater than that of a known antiviral, NBD-556, with 100% breadth against clade B and C viruses. Importantly, the compounds do not activate HIV infection of CD4-negative, CCR5-positive cells, in contrast to NBD-556. | 11-27-2014 |
20150044137 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Neutralizing antibodies that specifically bind to HIV-1 gp120 and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV infection is disclosed. | 02-12-2015 |
Ranee Kwong, Wappingers Falls, NY US
Patent application number | Description | Published |
---|---|---|
20140004712 | DEVELOPABLE BOTTOM ANTIREFLECTIVE COATING COMPOSITION AND PATTERN FORMING METHOD USING THEREOF | 01-02-2014 |
Ranee W. Kwong, Wappingers Falls, NY US
Patent application number | Description | Published |
---|---|---|
20110291284 | INTERCONNECT STRUCTURE WITH AN OXYGEN-DOPED SiC ANTIREFLECTIVE COATING AND METHOD OF FABRICATION - An interconnect structure is provided that includes at least one patterned and cured photo-patternable low k material located on a surface of a patterned and cured oxygen-doped SiC antireflective coating (ARC). A conductively filled region is located within the at least one patterned and cured photo-patternable low k material and the patterned and cured oxygen-doped SiC ARC. The oxygen-doped SiC ARC, which is a thin layer (i.e., less than 400 angstroms), does not produce standing waves that may degrade the diffusion barrier and the electrically conductive feature that are embedded within the patterned and cured photo-patternable low k dielectric material and, as such, structural integrity is maintained. Furthermore, since a thin oxygen-doped SiC ARC is employed, the plasma etch process time used to open the material stack of the ARC/dielectric cap can be reduced, thus reducing potential plasma damage to the patterned and cured photo-patternable low k material. Also, the oxygen-doped SiC ARC can withstand current BEOL processing conditions. | 12-01-2011 |
20150050601 | DEVELOPABLE BOTTOM ANTIREFLECTIVE COATING COMPOSITION AND PATTERN FORMING METHOD USING THEREOF - The present invention relates to a developable bottom antireflective coating (BARC) composition and a pattern forming method using the BARC composition. The BARC composition includes a first polymer having a first carboxylic acid moiety, a hydroxy-containing alicyclic moiety, and a first chromophore moiety; a second polymer having a second carboxylic acid moiety, a hydroxy-containing acyclic moiety, and a second chromophore moiety; a crosslinking agent; and a radiation sensitive acid generator. The first and second chromophore moieties each absorb light at a wavelength from 100 nm to 400 nm. In the patterning forming method, a photoresist layer is formed over a BARC layer of the BARC composition. After exposure, unexposed regions of the photoresist layer and the BARC layer are selectively removed by a developer to form a patterned structure in the photoresist layer. The BARC composition and the pattern forming method are especially useful for implanting levels. | 02-19-2015 |
Ranee Wai-Ling Kwong, Hopewell Junction, NY US
Patent application number | Description | Published |
---|---|---|
20110101507 | METHOD AND STRUCTURE FOR REWORKING ANTIREFLECTIVE COATING OVER SEMICONDUCTOR SUBSTRATE - A method and a structure for reworking an antireflective coating (ARC) layer over a semiconductor substrate. The method includes providing a substrate having a material layer, forming a planarization layer on the material layer, forming an organic solvent soluble layer on the planarization layer, forming an ARC layer on the organic solvent soluble layer, forming a pattern in the ARC layer, and removing the organic solvent soluble layer and the ARC layer with an organic solvent while leaving the planarization layer unremoved. The structure includes a substrate having a material layer, a planarization layer on the material layer, an organic solvent soluble layer on the planarization layer, and an ARC layer on the organic solvent soluble layer. | 05-05-2011 |
20120205786 | METHOD AND STRUCTURE FOR REWORKING ANTIREFLECTIVE COATING OVER SEMICONDUCTOR SUBSTRATE - A method and a structure for reworking an antireflective coating (ARC) layer over a semiconductor substrate. The method includes providing a substrate having a material layer, forming a planarization layer on the material layer, forming an organic solvent soluble layer on the planarization layer, forming an ARC layer on the organic solvent soluble layer, forming a pattern in the ARC layer, and removing the organic solvent soluble layer and the ARC layer with an organic solvent while leaving the planarization layer unremoved. The structure includes a substrate having a material layer, a planarization layer on the material layer, an organic solvent soluble layer on the planarization layer, and an ARC layer on the organic solvent soluble layer. | 08-16-2012 |
20120231554 | METHOD AND STRUCTURE FOR REWORKING ANTIREFLECTIVE COATING OVER SEMICONDUCTOR SUBSTRATE - A method and a structure for reworking an antireflective coating (ARC) layer over a semiconductor substrate. The method includes providing a substrate having a material layer, forming a planarization layer on the material layer, forming an organic solvent soluble layer on the planarization layer, forming an ARC layer on the organic solvent soluble layer, forming a pattern in the ARC layer, and removing the organic solvent soluble layer and the ARC layer with an organic solvent while leaving the planarization layer unremoved. The structure includes a substrate having a material layer, a planarization layer on the material layer, an organic solvent soluble layer on the planarization layer, and an ARC layer on the organic solvent soluble layer. | 09-13-2012 |
Ranee Wai-Ling Kwong, Wappingers Falls, NY US
Patent application number | Description | Published |
---|---|---|
20080248208 | APPARATUS AND METHOD FOR MEASURING THE QUANTITY OF CONDENSABLE MATERIALS WHICH OUTGAS DURING CURE OF ORGANIC THIN FILMS - An apparatus and method for measuring an amount of condensable material which outgas during cure of organic thin films. The apparatus includes a hotplate placed in a chamber having a removeable liner and means for cooling the liner. The method includes: weighing the liner, sequentially placing multiple substrates on said hotplate, and then weighing the liner again. | 10-09-2008 |
20090176174 | MULTIPLE EXPOSURE PHOTOLITHOGRAPHY METHODS AND PHOTORESIST COMPOSTIONS - A method and a composition. The composition includes a polymer and a photosensitive acid generator capable of generating a first amount of acid upon exposure to a first dose of radiation and a second amount of acid upon exposure to a second dose of radiation. The second amount of acid is greater than said first amount of acid. The second dose is greater than the first dose. The composition includes a photosensitive base generator capable of generating a first amount of base upon exposure to the first dose and a second amount of base upon exposure to the second dose, where the first amount of base is greater than the first amount of acid and the second amount of base is less than the second amount of acid. A method for exposing to radiation a film of a photoresist on a substrate is included. | 07-09-2009 |
20090214959 | PHOTORESIST COMPOSITIONS AND METHODS RELATED TO NEAR FIELD MASKS - A structure and a photolithography method. The method includes forming a first layer of a first photoresist including a first polymer and a first photosensitive acid generator. A second layer of a second photoresist, including a second polymer having at least one phenyl or phenolic moiety, is formed directly onto the first layer. The second layer is patternwise imaged, resulting in exposing at least one first portion. The first portion is removed, revealing at least one first region of the first layer. A second portion of the second layer remains forming a structure having opaque regions. The structure and first region are exposed. The opaque regions shield from radiation at least one second region of the first layer, resulting in producing acid in the first region and in the structure. The structure and base-soluble regions of the first layer are removed. A structure is also described. | 08-27-2009 |
20090214981 | PHOTORESISTS AND METHODS FOR OPTICAL PROXIMITY CORRECTION - Photolithography compositions and methods. A first layer of a first photoresist is formed on a substrate. A second layer of a second photoresist is formed directly onto the first layer. The second polymer of the second photoresist includes an absorbing moiety. The second layer is patternwise imaged and developed, resulting in removal of base-soluble regions. A relief pattern from the second layer remains. The relief pattern and the first layer are exposed to a second dose of the radiation. The polymer in the relief pattern absorbs a portion of the second dose. A fraction of the second dose passes through the at least one region of the relief pattern and exposes at least one region of the first layer. The relief pattern and base-soluble regions of the first layer are removed. A relief pattern from the first layer remains. A second photolithography method and a photoresist composition are also included. | 08-27-2009 |
20090291392 | WET DEVELOPABLE BOTTOM ANTIREFLECTIVE COATING COMPOSITION AND METHOD FOR USE THEREOF - The present invention discloses an antireflective coating composition for applying between a substrate surface and a positive photoresist composition. The antireflective coating composition is developable in an aqueous alkaline developer. The antireflective coating composition comprises a polymer, which comprises at least one monomer unit containing one or more moieties selected from the group consisting of a lactone, maleimide, and an N-alkyl maleimide; and at least one monomer unit containing one or more absorbing moieties. The polymer does not comprise an acid labile group. The present invention also discloses a method of forming and transferring a relief image by using the inventive antireflective coating composition in photolithography. | 11-26-2009 |
20120178027 | MULTIPLE EXPOSURE PHOTOLITHOGRAPHY METHODS - A method. The method forms a film of photoresist composition on a substrate and exposes a first and second region of the film to radiation through a first and second mask having a first and second image pattern, respectively. The photoresist composition includes a polymer including labile group(s), base soluble group(s), a photosensitive acid generator, and a photosensitive base generator. The photosensitive acid generator generates first and second amounts of acid upon exposure to first and second doses of radiation, respectively. The second amount of acid exceeds the first amount of acid. The second dose of radiation exceeds the first dose of radiation. The photosensitive base generator generates a first and second amount of base upon exposure to the first and second dose of radiation, respectively. The first amount of base exceeds the first amount of acid. The second amount of acid exceeds the second amount of base. | 07-12-2012 |
20120214099 | PHOTORESIST COMPOSITIONS - A composition. The composition includes a polymer and a photosensitive acid generator capable of generating a first amount of acid upon exposure to a first dose of radiation and a second amount of acid upon exposure to a second dose of radiation. The second amount of acid is greater than the first amount of acid. The second dose is greater than the first dose. The composition includes a photosensitive base generator capable of generating a first amount of base upon exposure to the first dose and a second amount of base upon exposure to the second dose, where the first amount of base is greater than the first amount of acid and the second amount of base is less than the second amount of acid. The photosensitive base generator may include benzoin carbamates, O-carbamoylhydroxylamines, O-carbamoyloximes, aromatic sulfonamides, α-lactones, N-(2-Arylethenyl)amides, azides, amides, oximines, quaternary ammonium salts, or amineimides. | 08-23-2012 |
20140349237 | EXPOSURE PHOTOLITHOGRAPHY METHODS - A method that forms a film of photoresist composition on a substrate and exposes a first and second region of the film to radiation through a first and second mask having a first and second image pattern, respectively. The photoresist composition includes a polymer comprising at least one acid labile group, a photosensitive acid generator capable of generating a first amount of acid upon exposure to a first dose of radiation and of generating a second amount of acid upon exposure to a second dose of radiation, and a photosensitive base generator capable of generating a first amount of base upon exposure to the first dose of radiation and of generating a second amount of base upon exposure to the second dose of radiation. The photosensitive acid generator includes (trifluoro-methylsulfonyloxy)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboximide (MDT), N-hydroxy-naphthalimide dodecane sulfonate (DDSN), or a combination thereof. The photosensitive base generator includes a quaternary ammonium salt. | 11-27-2014 |
Raymond Kwong, Ewing, NJ US
Patent application number | Description | Published |
---|---|---|
20140027734 | BORON-NITROGEN POLYAROMATIC COMPOUNDS AND THEIR USE IN OLEDS - Boron-nitrogen polyaromatic compounds having a fused aromatic ring system are provided, where the compounds include a [1,2]azaborino[1,2-a][1,2]azaborine | 01-30-2014 |
20150311449 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES - A compound that has the structure according to Formula 1: | 10-29-2015 |
Raymond Kwong, Westhampton, NJ US
Patent application number | Description | Published |
---|---|---|
20120267612 | CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES - Cross-linkable copper complexes comprising a copper phthalocyanine core and one or more cross-linkable functionalities linked to the phthalocyanine core. The copper complex may have a spacer group with the one or more cross-linkable functionalities on the spacer group. The spacer group contains a chain or one or more aryl groups. These cross-linkable copper complexes may be used in making organic electronic devices, such as OLEDs, by solution processing techniques. | 10-25-2012 |
Raymond Kwong, Holland, PA US
Patent application number | Description | Published |
---|---|---|
20140145149 | Organic Luminescent Compound With Delayed Fluorescence - Novel organic compounds containing an imidazole core and electron donor and acceptor fragments are provided. By selection of the disclosed donor and acceptor groups, compounds exhibiting small singlet-triplet gaps are obtained. These compounds are useful in OLED devices as host materials or as delayed fluorescent emitters. | 05-29-2014 |
Raymond C. Kwong, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20100289406 | 2-AZATRIPHENYLENE MATERIALS FOR ORGANIC LIGHT EMITTING DIODES - Compounds containing 2-azatriphenylene are provided. In particular, compounds containing a 2-azatriphenylene core having an additional aromatic group are provided. The compounds provided may be emissive or non-emissive materials. The compounds may be used in organic light emitting devices, particularly as host materials, hole blocking layer materials, or emitting dopants. Devices comprising 2-azatriphenylene containing compounds may demonstrate improved stability and efficiency. | 11-18-2010 |
20110278556 | Azaborinine Compounds As Host Materials And Dopants For PHOLEDs - Novel organic compounds comprising azaborine are provided. In particular, the compounds comprise a dibenzo-1,4,-azaborine core having a phenyl substituent on the boron atom, and aryl or heteroaryl substituents at positions 2 and 6 of the phenyl substituent. These compounds may be advantageously used in organic light-emitting devices to provide improved efficiency and lifetime. | 11-17-2011 |
20110279019 | AZABORININE COMPOUNDS AS HOST MATERIALS AND DOPANTS FOR PHOLEDS - Novel organic compounds comprising azaborine are provided. In particular, the compounds comprise a dibenzo-1,4,-azaborine core having a phenyl substituent on the boron atom, and aryl or heteroaryl substituents at positions 2 and 6 of the phenyl substituent. These compounds may be advantageously used in organic light-emitting devices to provide improved efficiency and lifetime. | 11-17-2011 |
20110304262 | Delayed-Fluorescence OLED - Novel organic compounds comprising a substituted anthracene or acridine ligand are provided. In particular, the compound includes an anthracene ligand substituted at the 9 and 10 positions. The compound may be used in organic light emitting devices to provide devices having improved efficiency and lifetime. In particular, these compounds may be especially beneficial for use in blue-emitting OLEDs. | 12-15-2011 |
20140110698 | EMITTER MATERIALS FOR OLEDS - Novel organic compounds comprising a substituted anthracene or acridine ligand are provided. In particular, the compound includes an anthracene ligand substituted at the 9 and 10 positions. The compound may be used in organic light emitting devices to provide devices having improved efficiency and lifetime. In particular, these compounds may be especially beneficial for use in blue-emitting OLEDs. | 04-24-2014 |
20140203268 | HETEROLEPTIC IRIDIUM COMPLEX - Novel compounds comprising heteroleptic iridium complexes are provided. The compounds have a particular combination of ligands which includes a single pyridyl dibenzo-substituted ligand. The compounds may be used in organic light emitting devices, particularly as emitting dopants, to provide devices having improved efficiency, lifetime, and manufacturing. | 07-24-2014 |
Raymond R. Kwong, Annapolis, MD US
Patent application number | Description | Published |
---|---|---|
20130036646 | Modular Accessory System For Rifle - A rifle is provided. The rifle comprises a barrel, a handguard partly axially surrounding the barrel, and a modular accessory system. The modular accessory system comprises a housing and a modular accessory support system positioned within the housing, wherein the support system includes at least two modular accessory slots. The modular accessory system also comprises a modular accessory removably secured and individually adjustable within each slot. The housing partly axially surrounds the barrel and is positioned axially adjacent to the handguard such that a combination of the handguard and the housing surrounds the barrel completely in an axial manner. Support system configurations of preferably either tray-type or platform-type may be contemplated. The modular accessory system may further comprise a common power source and a display system. A modular accessory system for rifles capable of exchangeably mounting accessories thereto in plug-and-play fashion is therefore achieved. | 02-14-2013 |
Rou-Fun Kwong, Westford, MA US
Patent application number | Description | Published |
---|---|---|
20140328859 | ANTIBODIES AND METHODS FOR WNT PATHWAY-RELATED DISEASES - The transmembrane E3 ubiquitin ligases ZNRF3 and RNF43 are negative regulators of β-catenin and the Wnt signaling pathway in eukaryotic cells. The activity of ZNRF3 can be modulated by antibody binding to its extracellular domain, thus causing an increase in Wnt signaling. The ZNRF3 antagonizing antibodies can be used to treat diseases with low Wnt signaling, such as short bowel syndrome, osteoporosis, diabetes, neurodegenerative diseases, and mucositis. In addition, the antagonizing antibodies of the invention can be used to enhance Wnt signaling for tissue repair and wound healing. | 11-06-2014 |
Rou-Fun Kwong, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20140134179 | TEM8 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE - Antibodies that specifically bind TEM8 protein, and conjugates thereof, are disclosed herein. In some examples the conjugates and antibodies are useful for methods of detecting and treating pathogenic angiogenesis. In other examples the conjugates and antibodies are useful for methods of detecting and treating cancer. In additional examples, the conjugates and antibodies are useful for methods of decreasing binding of Anthrax protective antigen to a cell. | 05-15-2014 |
Samson Kim-Sun Kwong, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20150326447 | Quality of User Experience Analysis Using Echo Locate - The techniques described herein involve analysis of client device Quality of Experience diagnostic files including an operations log or diagnostic files for a client device. The client device Quality of Experience diagnostic files may be generated by a client device and sent to a network node for analysis. The diagnostic files may be analyzed to determine device Key Performance Indicators and a device Quality of Experience, and to determine a root cause of a network problem (such as dropped calls) leading to a diminished Quality of Experience. In some embodiments, the diagnostic files may be aggregated to form a database of aggregated diagnostics, which can be used to further analyze a network to determine the root cause of a network problem. In some embodiments, the aggregated diagnostics may be indexed according to location, time, device type, device problem, or access technology. | 11-12-2015 |
Samuel Kwong, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20110112418 | ECG MONITORING SYSTEM WITH CONFIGURABLE ALARM LIMITS - An ECG monitoring system for ambulatory patients includes a small multi-electrode patch that adhesively attaches to the chest of a patient. A reusable battery-powered ECG monitor clips onto the patch and receives patient electrical signals from the electrodes of the patch. A processor continuously processes received ECG signals and analyzes the received ECG signals for pre-defined arrhythmia. If an arrhythmia is detected, a wireless transceiver in the ECG monitor transmits the event information and an ECG strip to a monitoring center. At the commencement of a monitoring procedure a message is sent to the monitoring center and configuration information for arrhythmia detection is down-loaded and installed in the monitor. The configuration file is determined by a screen of selectable standard and custom arrhythmias and alarm limits at the monitoring center. | 05-12-2011 |
20110125040 | WIRELESS ECG MONITORING SYSTEM - An ECG monitoring system for ambulatory patients includes a reusable battery-powered ECG monitor with an electrode attached to a patient for receiving ECG signals. A processor analyzes the received ECG signals for predefined arrhythmia. If an arrhythmia is detected, a wireless transceiver in the ECG monitor transmits the event information and an ECG strip to a cellphone handset. The cellphone handset automatically relays the event information and ECG strip to a monitoring center for further diagnosis and necessary intervention. The ECG monitor sends notifications to the cellphone handset whenever the status of the monitor changes. The cellphone handset forwards status notifications to which a patient response has not been received to the monitoring center, as well as status notifications generated by the cellphone handset. | 05-26-2011 |
Tony C. Kwong, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20080235196 | Confidential Content Search Engine - A security compliance search engine is provided for searching one or more client computing devices for items of information that meet a security criteria identifying items of information containing confidential content. Results of the search are provided to an analysis engine for determining if the items of information identified by the search are being maintained in accordance with a security policy for ensuring the confidentiality of the confidential content. Results of the analysis may be used to generate a report or log and to generate a notification to the client computing device identifying any violations of the security policy and possible solutions for bringing the item of information into compliance with the security policy. In addition, an administrator may be notified of any violations so that corrective action may be taken. | 09-25-2008 |
20080235760 | Confidential Content Reporting System and Method with Electronic Mail Verification Functionality - A confidential content reporting system and method with electronic mail verification functionality are provided. With the system and method, a security compliance search engine is provided for searching items of information to identify items containing confidential content and security violations with regard to this confidential content. Results of the search may be reported to a user via a graphical user interface (GUI) that identifies the item of information, the security violations detected, and suggested corrective actions, such as encryption. A user may interact with the GUI to apply security mechanisms in accordance with the suggested corrective actions. Moreover, the searching and reporting mechanism may be used to search electronic mail messages and their attachments prior to distribution of the electronic mail messages. Automatic modification of the electronic mail message to modify distribution lists and/or content of the electronic mail message may be performed using the mechanisms of the illustrative embodiments. | 09-25-2008 |
Wah Yiu Kwong, Hillsboro, OR US
Patent application number | Description | Published |
---|---|---|
20150222842 | DEVICE FOR ADAPTIVE PROJECTION - Embodiments of the invention describe apparatuses, systems and methods for dynamic projector calibration. Embodiments of the invention execute operations for capturing, via an image sensor included in a projector device, image data of an area around the projector device. Said image sensor captures 3D distance information as well as image pixel information of the surrounding area. A projection area is selected based (in part) on surface properties of the projection area determined from the image data. | 08-06-2015 |
Wah Yiu Y.u. Kwong, Beaverton, OR US
Patent application number | Description | Published |
---|---|---|
20140184521 | INTEGRATED CAMERA LENS AND TOUCH SCREEN COVER FOR AN ELECTRONIC DEVICE - Particular embodiments described herein provide a touch screen assembly for an electronic device, such as a laptop, notebook or tablet, having a camera module. The touch screen assembly includes a touch screen cover having a touch sensor layer extending across a portion of a surface of the touch screen cover, and a camera lens element integrated with the touch screen cover. The camera lens element is configured to be held at a predetermined distance with respect to the camera module of the electronic device. | 07-03-2014 |
Yat Wai Edwin Kwong US
Patent application number | Description | Published |
---|---|---|
20120110094 | ELECTRONIC MESSAGING SYSTEMS SUPPORTING PROVISION OF ENTIRE FORWARDING HISTORY REGARDING THE SENDING, RECEIVING, AND TIME ZONE INFORMATION, OF AN EMAIL AFTER THE EMAIL IS FORWARDED BY A NUMBER OF USERS - Systems and methods are provided for supporting provision of forwarding history of email information. In accordance with one implementation, a system is provided that includes supporting provisioning of entire forwarding history regarding the sending and receiving time zone information, of an email after the email has been forwarded by a number of users. The system is further configured to send, by the email sender, an email to the email receiver, through a email incoming server. Further, the system allows users to compose outgoing emails to another email receiver. In addition, the system includes sending the outgoing email, by the email receiver, to the other email receiver through a SMTP server. | 05-03-2012 |